Acute Leukemias Flashcards
Learn about the types of acute leukemias and their clinical presentations
Leukemia definition?
A hematological malignancy characterised by accumulation of immature cells or blasts in the bone marrow and eventually in the blood.
Classification of Leukemias?
Leukemias are generally classified into 2;
Acute and Chronic Leukemias.
Each however is subclassified based on the lineage of blasts cells into Myeloid and Lymphoid Lineages. ie
Acute Myloid Leukemia and Acute Lymphoid Leukemia
Chronic Myeloid Leukemia and Chronic Lymphoblastic Leukemia
Acute Leukemias
Aggresive disease in which immature progenitor cells/ balst cells accumulate in the bone marrow.
What is the diagnostic feature of acute Leukemia?
Presence of >30% of Blast cells in the bone marrow or blood at clinical presentation.
Epidemiology of Acute Leukemias?
Account for 50-60% of all leukemias with the myeloid types more common than the lymphoid types.
What is Acute Myeloid Leukemia?
Accumulation of immature myeloid blasts in the bone marrow due to oncogenic mutations that impede differentiation.
Age Distribution of AML?
Occurs at all ages but peaks at around ages 60 to 65
How are myeloblasts differentiated from Lymphoblasts?
- Presence of Auer Rods, which are purple crystalline cytoplasmic inclusions
- Coarse cytoplasmic granules when they show some maturation into promyelocytes
- Cytochemical or Immunological markers
What is the FAB classification?
A system of AML classification which divides AMLs based on the degree of diffenrentiation and also the lineage of leukemic blasts.
How many types of AMLs are present according to FAB.
Classifies AML from M0 to M7
WHO subdivides AML into how many types?
4
Make a statement on M0
M0 is the first type ofAML in the FAB classification.
Characterised by Myeloperoxidase negative blasts which are immature.
Myeloid antigens detected by Flow cytometry
5% of AmLs
what are the charecteristics of M1
Contains still immature blasts of which >3% are myeloperoxidase positive.
accounts for 15% of all AmLs
What are the Features of M2.
M2 cells show granulocytic maturation and hence abnormal cytoplasmic granules are present. Auer rods can also be seen .
t(8;21)(q22;22), t(6;9)
Features of M3?
Acute Promyeloctyic Leukemias . APLs.
Numerous Auer rods which often form bundles called faggots.
May have prominent granules / inconspicous in the micronodular type.
There is an increased incidence of DIC
Features of FAB M4?
Acute myelomonocytic leukemia. Usually due to inversion on chromosome 16.(p13q22) or a deletion.
A variant M4Eo is characterised by presence of Eosinophilic precursors with abnormal basophilic granules. Due to inversion on chr16 or a translocation. t(16;16)
Features and subclasses of M5?
M5 aka Acute monoblastic leukemia. subclassified into M5a and M5b
M5a is characterised by presence of non esterace positive monoblasts and promonoblasts.
M5b is characterised by presence of mature monocytes, and is commonly due to del(11q), t(9;11) , t(11;19)
What are the characteristics of M6?
M6 is characterised by presence of erythroid precursors mixed with myeloid blasts. Also subckassified into M6a and M6b.
M6a -erythroid/myeloid subtype.ddfined by >50% of erythroid precursors mixed with >20% myeloid blasts
M6b- Pure erythroid subtype. Defined by >80% of erythroid precursors without myeloblasts. Rare
Features of M7?
Acute Megakaryoblastic leukemia due to t(1;22). Xterized by blasts of megakaryocyte lineage. Detected with antibodies against megakaryocyte specific markers such as GpIIb/IIIa or vWF.
Most common AML in Down syndrome and associated with Marrow fibrosis
Describe the clinical presentation of a patient with AML?
》Weakness 》Shortness of breath 》Bleeding disorders 》easy fatigueability 》Weightloss and loss of appetite 》Fever
What are the Routine investigations to be carried out?
- FBC
2. Bone Marrow Aspirate
How is AML managed?
1.Chemotherapy
2.Radiation Therapy
3.Stem cell therapy.
4.Targeted therapy.
Note:Goal of treatment is to achieve complete remission
Prognosis?
60% achieve complete remission with chemo but only about 15 to 30% remain free after 5 years
AMLs with t(8;21)ie M2 and inv
(16), M4, have good prognosis with conventional chemo